Şunu aradınız:: endometrium (İngilizce - Maltaca)

endometrium
endometriju

effects on the endometrium:
effetti fuq l-endometriju:

effects on the postmenopausal endometrium
effetti fuq l-endometriju fi żmien ta’ wara l-menopawża

effects on the endometrium and on the pelvic floor
effetti fuq l-endometriju u l-qiegħ tal-pelvis

ulipristal acetate exerts a direct effect on the endometrium.
ulipristal acetate jeżerċita effett dirett fuq l-endometriju.

ulipristal acetate has a specific pharmacodynamic action on the endometrium:
ulipristal acetate għandu azzjoni farmakodinamika speċifika fuq l-endometriju:

little information is available on the effects of testosterone on the endometrium.
ftit informazzjoni hi disponibbli fuq l-effetti ta’ testosterone fuq l-endometriju.

in clinical trials, evista did not stimulate the postmenopausal uterine endometrium.
fi provi kliniċi, evista ma stimulatx l-endometriju ta’ l-utru fil-perijodu ta’ wara l-menopawsa.

absence of safety data on the endometrium for continuous treatment longer than 3 months.
nuqqas ta’ dejta dwar is-sigurtà fuq l-endometriju għal kura kontinwa itwal minn 3 xhur

it is not known whether intrinsa increases the risk of breast cancer and endometrium cancer.
mhux magħruf jekk intrinsa jżidx ir-riskju ta’ kanċer tas-sider u kanċer tal-endometriju.

changes in the histology of the endometrium may be observed in patients treated with ulipristal acetate.
bidliet fl-istoloġija tal-endometriju jistgħu jiġu osservati f’pazjenti kkurati b’ulipristal acetate.

in addition, reversible changes to the endometrium are denoted paec and are different from endometrial hyperplasia.
barra minn hekk, bidliet riversibbli lill-endometriju huma indikati bħala paec u huma differenti minn iperplażja endometrijali.

the direct action on the endometrium results in class-specific changes in histology termed paec.
l-azzjoni diretta fuq l-endometriju tirriżulta f’bidliet fl-istoloġija speċifiċi għall-klassi msejħa, paec.

as oestrogens promote the growth of the endometrium, unopposed oestrogens increase the risk of endometrial hyperplasia and cancer.
billi l-estroġeni jippromwovu t-tkabbir tal-endometriju, estroġeni mhux opposti jżidu r-riskju ta’ iperplasja endometrijali u kanċer.

the following results of the effects of fablyn on the endometrium through 5 years of exposure are reported from the pearl study.
ir-riżultati li ġejjin tal-effetti ta’ fablyn fuq l-endometriju matul l-ewwel 5 snin tal-esponiment ġew irrappurtati mill-istudju pearl.

endometrial biopsies taken after six months therapy with evista 60 mg daily demonstrated non- proliferative endometrium in all patients.
bijopsiji ta’ l-endometriju meħudin wara terapija ta’ 60 mg ta’ evista kuljum għal sitt xhur, urew endometriju mhux proliferattiv fil-pazjenti kollha.

changes in the lining of the uterus (endometrium), cancer of the lining of the womb (endometrial cancer)
bidliet fil-kisja tal-utru (endometriju), kanċer tal-kisja tal-utru (kanċer endometrijali)

if you have or have had cancer which is sensitive to oestrogens, such as cancer of the womb lining (endometrium), or if you are suspected of having it.
jekk inti għandek jew kellek kanċer li huwa sensittiv għall-estroġeni, bħal kanċer tat-tessut li jiksi l-utru (l-endometriju), jew jekk hemm suspett li għandek dan.

ioa works by changing the body’s hormonal balance to prevent ovulation, by altering the cervical mucus and by thinning the endometrium (the lining of the womb).
ioa jaħdem billi jibdel il-bilanċ ormonali tal-ġisem biex jimpedixxi l-ovulazzjoni, billi jibdel il-mukus ċervikali u billi jraqqaq l- endometriju (ir-rita tal-ġuf).

evra works like the pill by changing the body’s hormonal balance to prevent ovulation, by altering the cervical mucus and by thinning the endometrium (the lining of the womb).
evra jaħdem bħall-pillola billi jibdel il-bilanċ ormonali tal-ġisem biex jimpedixxi l-ovulazzjoni, billi jibdel il-mukus ċervikali u billi jraqqaq l-endometriju (rita tal-ġuf).